WASHINGTON — The U.S. Senate has passed a government funding bill that would give the nation’s embattled hemp industry roughly one more month before sweeping federal restrictions on hemp-derived THC products take effect.

The Senate approved the stopgap spending measure Saturday, August 8th at 3:58 a.m. EST in a 90-6 vote, funding the federal government through Dec. 11. Buried inside the legislation is a provision that would delay implementation of key portions of a federal hemp crackdown originally scheduled to take effect Nov. 12.

The measure still needs approval from the House of Representatives and President Donald Trump’s signature before it becomes law.

For hemp companies that have spent the past year preparing for what many have described as an existential threat to the industry, the provision amounts to a temporary reprieve—but not a solution.

Under legislation enacted last year, the federal definition of hemp is set to change from a standard based primarily on delta-9 THC to one based on total THC, including THCA and other forms of THC. Finished hemp-derived cannabinoid products would also be subject to a limit of 0.4 milligrams of total THC per container.

Those restrictions are expected to eliminate a large portion of the intoxicating hemp market, including many of the gummies, beverages and other products that have proliferated since the 2018 Farm Bill legalized hemp nationally.

The Senate spending bill would push the implementation date for most of those restrictions from Nov. 12 to Dec. 11.

That distinction is important. The legislation does not repeal the federal hemp restrictions or establish a permanent regulatory framework for hemp-derived THC. Instead, it gives lawmakers and the industry several additional weeks to find a longer-term solution.

Speaking exclusively via email to Cannabis Now, Morgan Tweet the CEO of IND Hemp response to this passage is pointed.

“After the drama surrounding a four week extension, we should be careful not to declare victory. Businesses will put every additional day to good use, but unless Congress immediately returns to the harder work of creating a permanent solution, this extension is barely a consolation prize.

The senators who opposed the extension are not fundamentally wrong about the need to protect children, remove noncompliant sellers and bring accountability to this marketplace. In fact, we now see them as some of the most important potential partners in building a lasting solution, one that replaces prohibition and uncertainty with smart rules, not a ban.

Congress has four more weeks. The goal cannot be another delay. It must be a comprehensive framework that protects consumers, gives responsible operators clear rules, opens markets for American farmers and preserves the future of industrial hemp. That is what the Goodness of Hemp campaign is working to deliver,” Morgan said.

The fight over the delay has exposed a growing divide in Washington over how the federal government should handle intoxicating hemp products.

Supporters of the crackdown have argued that products containing psychoactive cannabinoids have entered the national marketplace without adequate age restrictions, testing or consumer protections. Opponents, including hemp businesses and farmers, say an outright prohibition would wipe out legitimate businesses alongside bad actors and eliminate a market created under federal law.

The Senate considered an amendment from Sens. Ted Budd (R-N.C.) and Pete Ricketts (R-Neb.) that would have removed the delay and kept the November implementation date intact. The Senate rejected that effort, allowing the one-month extension to remain in the spending package.

For the hemp industry, the clock is still ticking.

The roughly four-week extension could give lawmakers additional time to consider proposals that would regulate intoxicating hemp rather than effectively eliminate much of the market. Industry advocates have pushed for approaches centered on age restrictions, testing, labeling and potency limits.

“This delay gives us the opportunity to move forward with reasonable, responsible legislation—one that addresses legitimate safety concerns while taking the first meaningful step toward creating a clear and durable regulatory framework for America’s hemp industry,” added Howard Lee the CEO of Sorse Technologies.

The stakes are substantial. The modern hemp-derived THC market emerged from the 2018 Farm Bill, which defined hemp according to a delta-9 THC threshold and opened the door to a rapidly expanding market for cannabinoids derived from hemp. Since then, products containing delta-8 THC, THCA and other cannabinoids have become widely available, with states taking sharply different approaches to regulation.

The federal government’s new rules were designed to close what lawmakers have characterized as a loophole. But the breadth of the changes has generated opposition from hemp farmers, processors, manufacturers and retailers who say the rules sweep far beyond intoxicating products and threaten legitimate portions of the hemp economy.

Now, the industry has approximately one additional month to make its case.

The Senate’s action does not guarantee that Congress will reach a permanent agreement before Dec. 11. Nor does it eliminate the possibility that the House could alter the provision or that the final legislation could take a different form.

For now, however, the November deadline has moved.

After months of preparing for a federal reckoning, hemp businesses have been handed something they desperately needed: more time.

The question is whether Washington will use it to build a regulatory framework—or simply postpone the same confrontation until December.

The post Senate Passes Spending Bill With One-Month Delay to Federal Hemp Crackdown appeared first on Cannabis Now.

Read More: Senate Passes Spending Bill With One-Month Delay to Federal Hemp Crackdown